Global Interstitial Lung Disease (ILD) Market Growth (Status and Outlook) 2025-2031

September 2025 | 83 pages | ID: G00B191496E0EN
LP Information

Abstracts

According to this study, the global Interstitial Lung Disease (ILD) market size will reach US$ million by 2031.

Interstitial Lung Disease (ILD), also referred to as pulmonary fibrosis or interstitial pneumonia, comprises a group of conditions characterized by varying degrees of inflammation and scarring around the tiny air sacs (alveoli) in the lungs. Interstitial Lung Disease treatment market in this report.

United States market for Interstitial Lung Disease (ILD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Interstitial Lung Disease (ILD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Interstitial Lung Disease (ILD) is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Interstitial Lung Disease (ILD) players cover Boehringer Ingelheim, Bellerophon Therapeutics, Inc, Bayer, Fujirebio (Miraca), Philips, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Interstitial Lung Disease (ILD) Industry Forecast” looks at past sales and reviews total world Interstitial Lung Disease (ILD) sales in 2024, providing a comprehensive analysis by region and market sector of projected Interstitial Lung Disease (ILD) sales for 2025 through 2031. With Interstitial Lung Disease (ILD) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interstitial Lung Disease (ILD) industry.

This Insight Report provides a comprehensive analysis of the global Interstitial Lung Disease (ILD) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Interstitial Lung Disease (ILD) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Interstitial Lung Disease (ILD) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interstitial Lung Disease (ILD) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interstitial Lung Disease (ILD).

This report presents a comprehensive overview, market shares, and growth opportunities of Interstitial Lung Disease (ILD) market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Interstitial Pneumonia
• Idiopathic Pulmonary Fibrosis
• Nonspecific Interstitial Pneumonitis
• Hypersensitivity Pneumonitis
• Cryptogenic Organizing Pneumonia
• Acute Interstitial Pneumonitis
• Desquamative Interstitial Pneumonitis
• Others

Segmentation by Application:

• Adults
• Children

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Boehringer Ingelheim
• Bellerophon Therapeutics, Inc
• Bayer
• Fujirebio (Miraca)
• Philips
• Merck
• Siemens Healthineers

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Interstitial Lung Disease (ILD) Market Size (2020-2031)
  2.1.2 Interstitial Lung Disease (ILD) Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Interstitial Lung Disease (ILD) by Country/Region (2020, 2024 & 2031)
2.2 Interstitial Lung Disease (ILD) Segment by Type
  2.2.1 Interstitial Pneumonia
  2.2.2 Idiopathic Pulmonary Fibrosis
  2.2.3 Nonspecific Interstitial Pneumonitis
  2.2.4 Hypersensitivity Pneumonitis
  2.2.5 Cryptogenic Organizing Pneumonia
  2.2.6 Acute Interstitial Pneumonitis
  2.2.7 Desquamative Interstitial Pneumonitis
  2.2.8 Others
2.3 Interstitial Lung Disease (ILD) Market Size by Type
  2.3.1 Interstitial Lung Disease (ILD) Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Interstitial Lung Disease (ILD) Market Size Market Share by Type (2020-2025)
2.4 Interstitial Lung Disease (ILD) Segment by Application
  2.4.1 Adults
  2.4.2 Children
2.5 Interstitial Lung Disease (ILD) Market Size by Application
  2.5.1 Interstitial Lung Disease (ILD) Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Interstitial Lung Disease (ILD) Market Size Market Share by Application (2020-2025)

3 INTERSTITIAL LUNG DISEASE (ILD) MARKET SIZE BY PLAYER

3.1 Interstitial Lung Disease (ILD) Market Size Market Share by Player
  3.1.1 Global Interstitial Lung Disease (ILD) Revenue by Player (2020-2025)
  3.1.2 Global Interstitial Lung Disease (ILD) Revenue Market Share by Player (2020-2025)
3.2 Global Interstitial Lung Disease (ILD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 INTERSTITIAL LUNG DISEASE (ILD) BY REGION

4.1 Interstitial Lung Disease (ILD) Market Size by Region (2020-2025)
4.2 Global Interstitial Lung Disease (ILD) Annual Revenue by Country/Region (2020-2025)
4.3 Americas Interstitial Lung Disease (ILD) Market Size Growth (2020-2025)
4.4 APAC Interstitial Lung Disease (ILD) Market Size Growth (2020-2025)
4.5 Europe Interstitial Lung Disease (ILD) Market Size Growth (2020-2025)
4.6 Middle East & Africa Interstitial Lung Disease (ILD) Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Interstitial Lung Disease (ILD) Market Size by Country (2020-2025)
5.2 Americas Interstitial Lung Disease (ILD) Market Size by Type (2020-2025)
5.3 Americas Interstitial Lung Disease (ILD) Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Interstitial Lung Disease (ILD) Market Size by Region (2020-2025)
6.2 APAC Interstitial Lung Disease (ILD) Market Size by Type (2020-2025)
6.3 APAC Interstitial Lung Disease (ILD) Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Interstitial Lung Disease (ILD) Market Size by Country (2020-2025)
7.2 Europe Interstitial Lung Disease (ILD) Market Size by Type (2020-2025)
7.3 Europe Interstitial Lung Disease (ILD) Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Interstitial Lung Disease (ILD) by Region (2020-2025)
8.2 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Type (2020-2025)
8.3 Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL INTERSTITIAL LUNG DISEASE (ILD) MARKET FORECAST

10.1 Global Interstitial Lung Disease (ILD) Forecast by Region (2026-2031)
  10.1.1 Global Interstitial Lung Disease (ILD) Forecast by Region (2026-2031)
  10.1.2 Americas Interstitial Lung Disease (ILD) Forecast
  10.1.3 APAC Interstitial Lung Disease (ILD) Forecast
  10.1.4 Europe Interstitial Lung Disease (ILD) Forecast
  10.1.5 Middle East & Africa Interstitial Lung Disease (ILD) Forecast
10.2 Americas Interstitial Lung Disease (ILD) Forecast by Country (2026-2031)
  10.2.1 United States Market Interstitial Lung Disease (ILD) Forecast
  10.2.2 Canada Market Interstitial Lung Disease (ILD) Forecast
  10.2.3 Mexico Market Interstitial Lung Disease (ILD) Forecast
  10.2.4 Brazil Market Interstitial Lung Disease (ILD) Forecast
10.3 APAC Interstitial Lung Disease (ILD) Forecast by Region (2026-2031)
  10.3.1 China Interstitial Lung Disease (ILD) Market Forecast
  10.3.2 Japan Market Interstitial Lung Disease (ILD) Forecast
  10.3.3 Korea Market Interstitial Lung Disease (ILD) Forecast
  10.3.4 Southeast Asia Market Interstitial Lung Disease (ILD) Forecast
  10.3.5 India Market Interstitial Lung Disease (ILD) Forecast
  10.3.6 Australia Market Interstitial Lung Disease (ILD) Forecast
10.4 Europe Interstitial Lung Disease (ILD) Forecast by Country (2026-2031)
  10.4.1 Germany Market Interstitial Lung Disease (ILD) Forecast
  10.4.2 France Market Interstitial Lung Disease (ILD) Forecast
  10.4.3 UK Market Interstitial Lung Disease (ILD) Forecast
  10.4.4 Italy Market Interstitial Lung Disease (ILD) Forecast
  10.4.5 Russia Market Interstitial Lung Disease (ILD) Forecast
10.5 Middle East & Africa Interstitial Lung Disease (ILD) Forecast by Region (2026-2031)
  10.5.1 Egypt Market Interstitial Lung Disease (ILD) Forecast
  10.5.2 South Africa Market Interstitial Lung Disease (ILD) Forecast
  10.5.3 Israel Market Interstitial Lung Disease (ILD) Forecast
  10.5.4 Turkey Market Interstitial Lung Disease (ILD) Forecast
10.6 Global Interstitial Lung Disease (ILD) Forecast by Type (2026-2031)
10.7 Global Interstitial Lung Disease (ILD) Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Interstitial Lung Disease (ILD) Forecast

11 KEY PLAYERS ANALYSIS

11.1 Boehringer Ingelheim
  11.1.1 Boehringer Ingelheim Company Information
  11.1.2 Boehringer Ingelheim Interstitial Lung Disease (ILD) Product Offered
  11.1.3 Boehringer Ingelheim Interstitial Lung Disease (ILD) Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Boehringer Ingelheim Main Business Overview
  11.1.5 Boehringer Ingelheim Latest Developments
11.2 Bellerophon Therapeutics, Inc
  11.2.1 Bellerophon Therapeutics, Inc Company Information
  11.2.2 Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Product Offered
  11.2.3 Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Bellerophon Therapeutics, Inc Main Business Overview
  11.2.5 Bellerophon Therapeutics, Inc Latest Developments
11.3 Bayer
  11.3.1 Bayer Company Information
  11.3.2 Bayer Interstitial Lung Disease (ILD) Product Offered
  11.3.3 Bayer Interstitial Lung Disease (ILD) Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Bayer Main Business Overview
  11.3.5 Bayer Latest Developments
11.4 Fujirebio (Miraca)
  11.4.1 Fujirebio (Miraca) Company Information
  11.4.2 Fujirebio (Miraca) Interstitial Lung Disease (ILD) Product Offered
  11.4.3 Fujirebio (Miraca) Interstitial Lung Disease (ILD) Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Fujirebio (Miraca) Main Business Overview
  11.4.5 Fujirebio (Miraca) Latest Developments
11.5 Philips
  11.5.1 Philips Company Information
  11.5.2 Philips Interstitial Lung Disease (ILD) Product Offered
  11.5.3 Philips Interstitial Lung Disease (ILD) Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Philips Main Business Overview
  11.5.5 Philips Latest Developments
11.6 Merck
  11.6.1 Merck Company Information
  11.6.2 Merck Interstitial Lung Disease (ILD) Product Offered
  11.6.3 Merck Interstitial Lung Disease (ILD) Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Merck Main Business Overview
  11.6.5 Merck Latest Developments
11.7 Siemens Healthineers
  11.7.1 Siemens Healthineers Company Information
  11.7.2 Siemens Healthineers Interstitial Lung Disease (ILD) Product Offered
  11.7.3 Siemens Healthineers Interstitial Lung Disease (ILD) Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Siemens Healthineers Main Business Overview
  11.7.5 Siemens Healthineers Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Interstitial Lung Disease (ILD) Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Interstitial Lung Disease (ILD) Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Interstitial Pneumonia
Table 4. Major Players of Idiopathic Pulmonary Fibrosis
Table 5. Major Players of Nonspecific Interstitial Pneumonitis
Table 6. Major Players of Hypersensitivity Pneumonitis
Table 7. Major Players of Cryptogenic Organizing Pneumonia
Table 8. Major Players of Acute Interstitial Pneumonitis
Table 9. Major Players of Desquamative Interstitial Pneumonitis
Table 10. Major Players of Others
Table 11. Interstitial Lung Disease (ILD) Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 12. Global Interstitial Lung Disease (ILD) Market Size by Type (2020-2025) & ($ millions)
Table 13. Global Interstitial Lung Disease (ILD) Market Size Market Share by Type (2020-2025)
Table 14. Interstitial Lung Disease (ILD) Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 15. Global Interstitial Lung Disease (ILD) Market Size by Application (2020-2025) & ($ millions)
Table 16. Global Interstitial Lung Disease (ILD) Market Size Market Share by Application (2020-2025)
Table 17. Global Interstitial Lung Disease (ILD) Revenue by Player (2020-2025) & ($ millions)
Table 18. Global Interstitial Lung Disease (ILD) Revenue Market Share by Player (2020-2025)
Table 19. Interstitial Lung Disease (ILD) Key Players Head office and Products Offered
Table 20. Interstitial Lung Disease (ILD) Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 21. New Products and Potential Entrants
Table 22. Mergers & Acquisitions, Expansion
Table 23. Global Interstitial Lung Disease (ILD) Market Size by Region (2020-2025) & ($ millions)
Table 24. Global Interstitial Lung Disease (ILD) Market Size Market Share by Region (2020-2025)
Table 25. Global Interstitial Lung Disease (ILD) Revenue by Country/Region (2020-2025) & ($ millions)
Table 26. Global Interstitial Lung Disease (ILD) Revenue Market Share by Country/Region (2020-2025)
Table 27. Americas Interstitial Lung Disease (ILD) Market Size by Country (2020-2025) & ($ millions)
Table 28. Americas Interstitial Lung Disease (ILD) Market Size Market Share by Country (2020-2025)
Table 29. Americas Interstitial Lung Disease (ILD) Market Size by Type (2020-2025) & ($ millions)
Table 30. Americas Interstitial Lung Disease (ILD) Market Size Market Share by Type (2020-2025)
Table 31. Americas Interstitial Lung Disease (ILD) Market Size by Application (2020-2025) & ($ millions)
Table 32. Americas Interstitial Lung Disease (ILD) Market Size Market Share by Application (2020-2025)
Table 33. APAC Interstitial Lung Disease (ILD) Market Size by Region (2020-2025) & ($ millions)
Table 34. APAC Interstitial Lung Disease (ILD) Market Size Market Share by Region (2020-2025)
Table 35. APAC Interstitial Lung Disease (ILD) Market Size by Type (2020-2025) & ($ millions)
Table 36. APAC Interstitial Lung Disease (ILD) Market Size by Application (2020-2025) & ($ millions)
Table 37. Europe Interstitial Lung Disease (ILD) Market Size by Country (2020-2025) & ($ millions)
Table 38. Europe Interstitial Lung Disease (ILD) Market Size Market Share by Country (2020-2025)
Table 39. Europe Interstitial Lung Disease (ILD) Market Size by Type (2020-2025) & ($ millions)
Table 40. Europe Interstitial Lung Disease (ILD) Market Size by Application (2020-2025) & ($ millions)
Table 41. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Region (2020-2025) & ($ millions)
Table 42. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Type (2020-2025) & ($ millions)
Table 43. Middle East & Africa Interstitial Lung Disease (ILD) Market Size by Application (2020-2025) & ($ millions)
Table 44. Key Market Drivers & Growth Opportunities of Interstitial Lung Disease (ILD)
Table 45. Key Market Challenges & Risks of Interstitial Lung Disease (ILD)
Table 46. Key Industry Trends of Interstitial Lung Disease (ILD)
Table 47. Global Interstitial Lung Disease (ILD) Market Size Forecast by Region (2026-2031) & ($ millions)
Table 48. Global Interstitial Lung Disease (ILD) Market Size Market Share Forecast by Region (2026-2031)
Table 49. Global Interstitial Lung Disease (ILD) Market Size Forecast by Type (2026-2031) & ($ millions)
Table 50. Global Interstitial Lung Disease (ILD) Market Size Forecast by Application (2026-2031) & ($ millions)
Table 51. Boehringer Ingelheim Details, Company Type, Interstitial Lung Disease (ILD) Area Served and Its Competitors
Table 52. Boehringer Ingelheim Interstitial Lung Disease (ILD) Product Offered
Table 53. Boehringer Ingelheim Interstitial Lung Disease (ILD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Boehringer Ingelheim Main Business
Table 55. Boehringer Ingelheim Latest Developments
Table 56. Bellerophon Therapeutics, Inc Details, Company Type, Interstitial Lung Disease (ILD) Area Served and Its Competitors
Table 57. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Product Offered
Table 58. Bellerophon Therapeutics, Inc Interstitial Lung Disease (ILD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Bellerophon Therapeutics, Inc Main Business
Table 60. Bellerophon Therapeutics, Inc Latest Developments
Table 61. Bayer Details, Company Type, Interstitial Lung Disease (ILD) Area Served and Its Competitors
Table 62. Bayer Interstitial Lung Disease (ILD) Product Offered
Table 63. Bayer Interstitial Lung Disease (ILD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Bayer Main Business
Table 65. Bayer Latest Developments
Table 66. Fujirebio (Miraca) Details, Company Type, Interstitial Lung Disease (ILD) Area Served and Its Competitors
Table 67. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Product Offered
Table 68. Fujirebio (Miraca) Interstitial Lung Disease (ILD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Fujirebio (Miraca) Main Business
Table 70. Fujirebio (Miraca) Latest Developments
Table 71. Philips Details, Company Type, Interstitial Lung Disease (ILD) Area Served and Its Competitors
Table 72. Philips Interstitial Lung Disease (ILD) Product Offered
Table 73. Philips Interstitial Lung Disease (ILD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Philips Main Business
Table 75. Philips Latest Developments
Table 76. Merck Details, Company Type, Interstitial Lung Disease (ILD) Area Served and Its Competitors
Table 77. Merck Interstitial Lung Disease (ILD) Product Offered
Table 78. Merck Interstitial Lung Disease (ILD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Merck Main Business
Table 80. Merck Latest Developments
Table 81. Siemens Healthineers Details, Company Type, Interstitial Lung Disease (ILD) Area Served and Its Competitors
Table 82. Siemens Healthineers Interstitial Lung Disease (ILD) Product Offered
Table 83. Siemens Healthineers Interstitial Lung Disease (ILD) Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Siemens Healthineers Main Business
Table 85. Siemens Healthineers Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Interstitial Lung Disease (ILD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Interstitial Lung Disease (ILD) Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Interstitial Lung Disease (ILD) Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Interstitial Lung Disease (ILD) Sales Market Share by Country/Region (2024)
Figure 8. Interstitial Lung Disease (ILD) Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Interstitial Lung Disease (ILD) Market Size Market Share by Type in 2024
Figure 10. Interstitial Lung Disease (ILD) in Adults
Figure 11. Global Interstitial Lung Disease (ILD) Market: Adults (2020-2025) & ($ millions)
Figure 12. Interstitial Lung Disease (ILD) in Children
Figure 13. Global Interstitial Lung Disease (ILD) Market: Children (2020-2025) & ($ millions)
Figure 14. Global Interstitial Lung Disease (ILD) Market Size Market Share by Application in 2024
Figure 15. Global Interstitial Lung Disease (ILD) Revenue Market Share by Player in 2024
Figure 16. Global Interstitial Lung Disease (ILD) Market Size Market Share by Region (2020-2025)
Figure 17. Americas Interstitial Lung Disease (ILD) Market Size 2020-2025 ($ millions)
Figure 18. APAC Interstitial Lung Disease (ILD) Market Size 2020-2025 ($ millions)
Figure 19. Europe Interstitial Lung Disease (ILD) Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Interstitial Lung Disease (ILD) Market Size 2020-2025 ($ millions)
Figure 21. Americas Interstitial Lung Disease (ILD) Value Market Share by Country in 2024
Figure 22. United States Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Interstitial Lung Disease (ILD) Market Size Market Share by Region in 2024
Figure 27. APAC Interstitial Lung Disease (ILD) Market Size Market Share by Type (2020-2025)
Figure 28. APAC Interstitial Lung Disease (ILD) Market Size Market Share by Application (2020-2025)
Figure 29. China Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 33. India Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Interstitial Lung Disease (ILD) Market Size Market Share by Country in 2024
Figure 36. Europe Interstitial Lung Disease (ILD) Market Size Market Share by Type (2020-2025)
Figure 37. Europe Interstitial Lung Disease (ILD) Market Size Market Share by Application (2020-2025)
Figure 38. Germany Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 39. France Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Interstitial Lung Disease (ILD) Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Interstitial Lung Disease (ILD) Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Interstitial Lung Disease (ILD) Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Interstitial Lung Disease (ILD) Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 52. APAC Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 53. Europe Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 55. United States Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 56. Canada Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 57. Mexico Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 58. Brazil Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 59. China Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 60. Japan Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 61. Korea Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 63. India Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 64. Australia Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 65. Germany Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 66. France Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 67. UK Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 68. Italy Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 69. Russia Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 70. Egypt Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 71. South Africa Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 72. Israel Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 73. Turkey Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)
Figure 74. Global Interstitial Lung Disease (ILD) Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Interstitial Lung Disease (ILD) Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Interstitial Lung Disease (ILD) Market Size 2026-2031 ($ millions)